Clinical Trial Matching Service
Oncology (Broad)
CommercialActive
Key Facts
About Perthera
Perthera is a leader in AI-driven precision oncology, offering a comprehensive platform that integrates multi-omic testing results and patient history to match cancer patients with ranked therapy options. Its core product, the Perthera Report®, is used by oncologists to optimize treatment decisions and streamline clinical workflows, while its data pipeline supports real-world evidence generation and clinical trial matching. The company has established a significant footprint, with its platform reportedly used in 600 hospitals/clinics and by 10% of US medical oncologists, and it demonstrates strong clinical impact metrics, including a 2.4x improvement in progression-free survival for its patients.
View full company profileTherapeutic Areas
Other Oncology (Broad) Drugs
| Drug | Company | Phase |
|---|---|---|
| Functional Precision Oncology Platform Validation | Known Medicine | Pre-clinical |
| Clinical Trial Program | VitroScan | N/A (Diagnostic Validation) |
| Personalized Treatment Screening | Okomera | Pre-clinical |
| Preclinical Drug Discovery Services | Okomera | Pre-clinical |
| RWE Data Pipeline | Perthera | Commercial |
| Enhanced Liquid Biopsy Platform | Wobble Genomics | Platform Validation |
| Live Tissue Biobanking Service | SpeciCare | Service |
| Ex Vivo Therapy Testing | SpeciCare | Research |
| Personalized Vaccine Support | SpeciCare | Research |
| Clinical Trial Matching & Access | SpeciCare | Service |
| Organoid Creation & Biobanking | SpeciCare | Research |